SuperworthGuardian Pharmacy Services EPS GRDN
Diluted earnings per share by quarter and over the last twelve months, from 2024.
- Last 12 months, to Jun 30, 2026
- $1.03
- Latest quarter, Q2 FY26
- $0.34
- +143% on a year earlier
- Fiscal year 2025
- $0.77
Guardian Pharmacy Services' earnings per share was $1.03 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.34, up 143% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.77 | n/a |
| FY2024 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.34 | +143% | $1.03 | |
| Q1 FY26 | $0.21 | +40% | $0.83 | |
| Q4 FY25 | $0.33 | +83% | $0.77 | |
| Q3 FY25 | $0.15 | n/a | $0.62 | |
| Q2 FY25 | $0.14 | n/a | −$1.53 | |
| Q1 FY25 | $0.15 | n/a | n/a | |
| Q4 FY24 | $0.18 | n/a | n/a | |
| Q3 FY24 | −$2.00 | n/a | n/a |
Against its peers
Companies in Healthcare nearest Guardian Pharmacy Services' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GRDNGuardian Pharmacy Services | $1.03 | |
| TMDXTransMedics | $3.84 | +99% a year |
| ADMAAdma Biologics | $0.70 | −18% a year |
| MDPediatrix Medical | $2.09 | +62% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| ADUSAddus HomeCare | $5.70 | +26% a year |
| PBHPrestige Consumer Healthcare | $3.57 | −16% a year |
| NRIXNurix Therapeutics | $2.31 | |
| PGNYProgyny | $0.92 | +56% a year |
| PRVAPrivia Health | $0.21 | +91% a year |
| VCELVericel | $0.46 | +283% a year |
| Peer median | $2.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Guardian Pharmacy Services
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.